# Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment

> **NCT00178854** · PHASE4 · WITHDRAWN · sponsor: **Vanderbilt University Medical Center**

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00178854
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2004-05
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** failed recruitment efforts
- **Last updated:** 2017-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00178854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00178854, "Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00178854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*